Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Optimized Thiopurine Therapy in Ulcerative Colitis (OPTIC)

NCT02910245 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT02910245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02910245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Optimized Thiopurine Therapy in Ulcerative Colitis (OPTIC)
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2016
Completion date
April 30, 2022
Enrollment
136 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative